Pharmaceuticals & Therapeutics

A new partnership aims to accelerate a pipeline of innovative multi-functional fusion proteins, potentially reshaping treatment for cancer and autoimmune disease.

Aja Health inks a deal with Greatway Financial to sell its MyCare Ally program and upgrades its GOeVisit platform for advanced virtual care services.

Flexible Solutions posts modest 2025 revenue gains, but a major strategic shift to food-grade products and new factories sets the stage for a breakout year.

Privo Technologies reports its PRV211 patch was well-tolerated in a key trial, offering a new, localized approach to preventing oral cancer recurrence.

Swiss biotech GeNeuro suspends trading, awaiting a critical court ruling on its debt moratorium that will decide its fate and the future of its novel drugs.

As Embecta prepares its Q1 results, investors watch closely to see if its move beyond insulin can reverse recent revenue declines and reshape its future.

A new telehealth pharmacy offers flat-rate annual pricing for compounded weight loss drugs, challenging high costs but raising questions about regulation.

PAQ Therapeutics advances its pan-KRAS degrader into human trials, backed by a $77M funding round, offering new hope for notoriously tough cancers.

With demand soaring, diagnostics leader PreludeDx hires veteran MiMi Reyes to scale lab operations and spearhead the launch of its new AidaBreast test.

With two major trial results looming, Zura Bio appoints Sandeep Kulkarni, who led Tourmaline to a Novartis sale, to navigate its high-stakes future.

A new journal issue reveals how venture capital, advanced clinical insights, and patient-centered drug design are creating a new era in heart failure care.

A clinical trial for D-Serine begins in Norway, testing a novel approach that could finally slow or halt the progression of Parkinson's disease.

A new partnership integrates advanced imaging and ablation tech, aiming to revolutionize pain treatment as procedures shift from hospitals to clinics.

Canadian giant Aurora Cannabis gains exclusive EU rights for two key strains, signaling a new era of genetic ownership in Europe's booming medical market.

As CRNA Week begins, a closer look reveals these highly trained nurses are essential for rural access, patient safety, and healthcare system stability.

Carrying the Alzheimer's gene, a longevity expert has turned himself into a public experiment, documenting his radical protocol to prevent the disease.

Australian biopharma Immuron reports strong global sales for its travel supplement and launches a new IBS product, navigating industry mergers and digital trends.

Shanghai's premier electronics expo sets the stage for a new manufacturing era, showcasing embodied AI, new energy vehicles, and revolutionary medical tech.

Genmab's antibody drug epcoritamab is the first of its kind to slow cancer progression in a Phase 3 trial for R/R DLBCL, offering a new path for patients.

South Korean researchers created a 'Janus' patch that bonds to wet tissue in seconds, preventing dangerous leaks and complications in neurosurgery.